Cancer stem cells (CSCs) market is anticipated to grow at a significant CAGR during the forecast period. Cancer stem cells (CSCs) are self-renewable cell types that are found in most types of liquid and solid cancers and are responsible for tumor beginning, its growth, resistance, recurrence, and metastasis after therapy. CSCs are identified from the expression of cell surface markers, which is tumor-type dependent. At present, the therapeutics related to oncology have evolved and exceeded the conventional therapies including the chemotherapy, radiotherapy, and surgeries, since all these have their certain limitations. This is anticipated to spur the market growth of CSCs. As per the journal released by the National Center for Biotechnology Information (NCBI) in September 2012, the clinical significance of CSCs has been reinforced by emerging evidence, demonstrating that CSCs are resistant to conventional chemotherapy and radiation treatment.
Further, CSCs are considered to be a key target for novel anti-cancer drug discovery. Thus, innovations in the field of oncology therapeutics are anticipated to augment the market growth. In the past couple of years, stem cells have been successfully utilized in immuno-reconstitution and for replenishment of blood after tumor development and at times, even after its treatment. In addition to this, these cells have gained substantial attention in the healthcare entities for its utilization as an effective tool in the delivery of anti-cancer agents along with the purpose of tissue regeneration.
To Request a Sample of our Report on Cancer Stem Cells (CSCs) Market: https://www.omrglobal.com/request-sample/cancer-stem-cells-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
Segment Covered-
- By Mode of Action
- By Cancer Forms
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Thermo Fisher Scientific, Inc., AbbVie Inc., and Merck KGaA, among others.
Cancer Stem Cells Market Report by Segment
By Mode of Action
- Stem-Cell Based Cancer Therapy
- Targeted Cancer Stem Cell Therapy
By Cancer Forms
- Breast Cancer
- Blood Cancer
- Lung Cancer
- Brain Cancer
- Others
A full Report of Cancer Stem Cells (CSCs) Market is Available @ https://www.omrglobal.com/industry-reports/cancer-stem-cells-market
Cancer Stem Cells Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
